Plunkett Research Online: Ampio Pharmaceuticals Inc

AMPIO PHARMACEUTICALS INC (AMPE:ASE) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Ampio Pharmaceuticals, Inc. develops drugs to treat metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The firm’s product pipeline includes certain FDA approved drugs, now targeted at new clinical indications protected by its intellectual property and new molecular entitie.....



Ampio Pharmaceuticals Inc
Ticker: AMPE
Exchange: ASE
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 720 437-6500
Fax: 720 437-6501
Address: 373 Inverness Parkway
Suite 200
Englewood, CO 80112 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Michael MacalusoCEO/Chairman of the Board/Director
Thomas ChilcottCFO/Chief Accounting Officer/Secretary/Treasurer
See More
Ampio Pharmaceuticals, Inc. develops drugs to treat metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The firm’s product pipeline includes certain FDA approved drugs, now targeted at new clinical indications protected by its intellectual property and new molecular entitie.....See More See More

Auditor: EKS&H LLLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: